Extrahepatic Obstructive Cholestasis Reverses the Bile Salt Secretory Polarity of Rat Hepatocytes
Overview
Authors
Affiliations
To elucidate the consequences of extrahepatic cholestasis on the structure and function of hepatocytes, we studied the effects of bile duct ligation on the turnover, surface distribution, and functional activity of the canalicular 100-kD bile salt transport protein (cBSTP). Basolateral (blLPM) and canalicular (cLPM) liver plasma membrane vesicles were purified to the same degree from normal and cholestatic rat livers and the membrane bound cBSTP identified and quantitated using polyclonal anti-cBSTP antibodies. Cholestasis of 50 h resulted in an increased release of cBSTP into bile, thereby decreasing its in vivo half-life from 65 to 25 h. Furthermore, a significant portion of cBSTP accumulated at the basolateral surface and in intracellular vesicles of cholestatic hepatocytes. This redistribution of cBSTP was functionally paralleled by decreased and increased electrogenic taurocholate anion transport in cLPM and blLPM vesicles, respectively. These results demonstrate that biliary obstruction causes a reversal of the bile salt secretory polarity of rat hepatocytes. The resulting increase in basolateral (sinusoidal) bile salt efflux might protect hepatocytes from too high an accumulation of toxic bile salts within the cell interior.
Structural and functional hepatocyte polarity and liver disease.
Gissen P, Arias I J Hepatol. 2015; 63(4):1023-37.
PMID: 26116792 PMC: 4582071. DOI: 10.1016/j.jhep.2015.06.015.
Treyer A, Musch A Compr Physiol. 2013; 3(1):243-87.
PMID: 23720287 PMC: 3697931. DOI: 10.1002/cphy.c120009.
Versland M, Wu G, Gorelick F, Larkin J Dig Dis Sci. 1997; 42(11):2246-53.
PMID: 9398802 DOI: 10.1023/a:1018810500006.
Adaptation of intestinal nutrient transport in health and disease. Part II.
Thomson A, Wild G Dig Dis Sci. 1997; 42(3):470-88.
PMID: 9073127 DOI: 10.1023/a:1018874404762.
Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver.
BOSSARD R, Stieger B, ONeill B, Fricker G, Meier P J Clin Invest. 1993; 91(6):2714-20.
PMID: 8514879 PMC: 443336. DOI: 10.1172/JCI116511.